Get access

Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts

Authors

  • Rosário Monteiro,

    1. Department of Biochemistry, Faculty of Medicine, University of Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
    2. Faculty of Nutrition and Food Sciences, University of Porto, 4200-465 Porto, Portugal
    Search for more papers by this author
  • Conceição Calhau,

    1. Department of Biochemistry, Faculty of Medicine, University of Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
    Search for more papers by this author
  • Artur Oliveira e Silva,

    1. Surgical Pathology Department, S. João Hospital, 4200-319 Porto, Portugal
    Search for more papers by this author
  • Sandra Pinheiro-Silva,

    1. Faculty of Nutrition and Food Sciences, University of Porto, 4200-465 Porto, Portugal
    2. Medical Oncology Department, S. João Hospital, 4200-319 Porto, Portugal
    Search for more papers by this author
  • Susana Guerreiro,

    1. Department of Biochemistry, Faculty of Medicine, University of Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
    Search for more papers by this author
  • Fátima Gärtner,

    1. Institute of Molecular Pathology and Immunology, University of Porto, 4200-465 Porto, Portugal
    Search for more papers by this author
  • Isabel Azevedo,

    1. Department of Biochemistry, Faculty of Medicine, University of Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
    Search for more papers by this author
  • Raquel Soares

    Corresponding author
    1. Department of Biochemistry, Faculty of Medicine, University of Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
    • Department of Biochemistry, Faculty of Medicine of the University of Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
    Search for more papers by this author

Abstract

Xanthohumol (XN), a natural polyphenol present in beer, is known to exert anti-cancer effects. However, its precise mechanisms are not yet clearly defined. The aim of this study was to investigate the effect of oral administration of XN in breast cancer xenografts in nude mice. Proliferation and apoptosis were first examined in MCF7 cell cultures after incubation with XN by trypan blue exclusion assay, [3H]-thymidine incorporation, KI67 immunostaining and TUNEL. Morphological and histological characteristics of tumours from XN-treated or control (vehicle-treated) mice were compared. Immunohistochemistry for proliferative, inflammatory and endothelial cell markers was performed and activation of nuclear factor kappa B (NFκB) pathway was assessed by ELISA. In vitro MCF7 cell proliferation decreased in a dose-dependent manner. Oral administration of XN to nude mice inoculated with MCF7 cells resulted in central necrosis within tumours, reduced inflammatory cell number, focal proliferation areas, increased percentage of apoptotic cells and decreased microvessel density. Anti-angiogenic effects of XN were further confirmed by immunoblotting for factor VIII expression in XN-treated tumours as compared to controls. Decreased immunostaining for NFκB, phosphorylated-inhibitor of kappa B and interleukin-1β were also observed as well as a significant decrease in NFκB activity to 60% of control values. These novel findings indicate that XN is able to target both breast cancer and host cells, namely inflammatory and endothelial cells, suggesting its potential use as a double-edge anti-cancer agent. J. Cell. Biochem. 104: 1699–1707, 2008. © 2008 Wiley-Liss, Inc.

Get access to the full text of this article

Ancillary